Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Sight Sciences, Inc.
NASDAQ:SGHTHealthcare · Medical - Devices
-2.61%$9.32
AH$9.32+0.00%vs close
Mkt Cap$513.42M
Float36.87M
O/S55.09M
Vol
$ Vol
RVOL
Inst Own37.1%
SI3.4%
Earnings
Dilution
Financials Summary
Revenue$77.36M
Net Income-$38.43M
Total Assets$115.3M
Free Cash Flow-$29.92M
Debt & Equity
Debt 39%
Equity 61%
Total Debt$40.77M
Total Equity$63.94M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SGHT's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$115.3M
Liabilities$51.36M
Accounts Receivable$9.74M
Accounts Payable$1.34M
Inventory$7.77M
PP&E (Net)$2.05M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $77.36M | $79.87M | $81.06M | $71.33M | $48.96M | $27.64M | $23.35M | $7.53M |
| YoY Growth | -3.1% | -1.5% | 13.6% | 45.7% | 77.1% | 18.4% | 210.1% | - |
| Cost of Revenue | $10.7M | $11.58M | $11.88M | $12.36M | $8.61M | $9.21M | $6.54M | $2.34M |
| Gross Profit | $66.67M | $68.28M | $69.17M | $58.97M | $40.35M | $18.43M | $16.8M | $5.19M |
| Gross Margin | 86.2% | 85.5% | 85.3% | 82.7% | 82.4% | 66.7% | 72.0% | 69.0% |
| Research and Development | $14.61M | $17.99M | $17.56M | $22.86M | $15.63M | $8.87M | $8.12M | $5.43M |
| Selling, General, and Administrative | $89.16M | $100.83M | $108.89M | $120.06M | $76.19M | $41.74M | $32.72M | $14.06M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $103.77M | $118.82M | $126.45M | $142.92M | $91.82M | $50.62M | $40.84M | $19.49M |
| Operating Income (EBIT) | -$37.1M | -$50.53M | -$57.27M | -$83.95M | -$51.48M | -$32.19M | -$24.04M | -$14.3M |
| Operating Margin | -48.0% | -63.3% | -70.7% | -117.7% | -105.2% | -116.5% | -103.0% | -189.9% |
| Interest Expense | $5.14M | $4.66M | $5.41M | $4.47M | $4.37M | $2.4M | $1.96M | $0 |
| Interest Income | $3.97M | $0 | $0 | $0 | $0 | $30K | $174K | $1K |
| Other Income (Expense) | -$1.32M | -$739K | $1.84M | -$2.24M | -$11.29M | -$2.44M | -$1.82M | $1K |
| Income Before Tax (EBT) | -$38.42M | -$51.27M | -$55.44M | -$86.19M | -$62.77M | -$34.63M | -$25.86M | -$14.3M |
| Income Tax Expense | $10K | $236K | $110K | $47K | $188K | $61K | $8K | -$6K |
| Net Income | -$38.43M | -$51.51M | -$55.55M | -$86.24M | -$62.96M | -$34.69M | -$25.87M | -$14.29M |
| Net Income Margin | -49.7% | -64.5% | -68.5% | -120.9% | -128.6% | -125.5% | -110.8% | -189.8% |
| Supplementary Data | ||||||||
| EPS | -0.74 | -1.03 | -1.14 | -1.80 | -1.33 | -0.74 | -0.55 | -0.44 |
| Diluted EPS | -0.74 | -1.03 | -1.14 | -1.80 | -1.33 | -0.74 | -0.77 | -0.44 |
| Weighted Average OS | 52.15M | 50.13M | 48.63M | 47.85M | 47.50M | 46.77M | 33.63M | 32.20M |
| EBITDA | -$32.79M | -$45.9M | -$49.41M | -$81.02M | -$57.77M | -$31.68M | -$23.61M | -$14.23M |
| EBITDA Margin | -42.4% | -57.5% | -61.0% | -113.6% | -118.0% | -114.6% | -101.1% | -189.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $91.97M | $120.36M | $138.13M | $185M | $260.69M | $61.51M | $21.24M | $4.24M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $91.97M | $120.36M | $138.13M | $185M | $260.69M | $61.51M | $21.24M | $4.24M |
| Accounts Receivable | $9.74M | $10.79M | $14.29M | $15.15M | $8.71M | $5.36M | $4.09M | $1.81M |
| Inventory | $7.77M | $6.33M | $7.85M | $6.11M | $3.48M | $2.6M | $2.24M | $486K |
| Other Current Assets | $3.26M | $2.31M | $2.6M | $3.42M | $1 | $0 | $0 | $0 |
| Total Current Assets | $112.73M | $139.77M | $162.87M | $209.68M | $277.04M | $70.63M | $28M | $7.16M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $2.05M | $2.52M | $3.1M | $3.19M | $2.95M | $1.79M | $2.57M | $868K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $518K | $550K | $682K | $211K | $202K | $386K | $168K | $62K |
| Total Long-Term Assets | $2.57M | $3.06M | $3.78M | $3.4M | $3.15M | $2.17M | $2.74M | $930K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $115.3M | $142.84M | $166.65M | $213.07M | $280.19M | $72.81M | $30.74M | $8.09M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $1.34M | $1.69M | $1.73M | $2.69M | $3.35M | $2.16M | $2.31M | $1.88M |
| Short-Term Debt | $0 | $0 | $2.22M | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $6.07M | $9.68M | $4.53M | $7.35M | $5.99M | $4.07M | $0 | $328K |
| Total Current Liabilities | $11.03M | $15.47M | $12.25M | $17.82M | $13.5M | $9.31M | $7.34M | $2.9M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $40.3M | $39.36M | $31.71M | $33.31M | $32.66M | $31.95M | $12.86M | $34.15M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $31K | $19K | $1.56M | $1.23M | $879K | $120.25M | $64.7M | $7K |
| Total Long-Term Liabilities | $40.33M | $39.85M | $34.18M | $35.18M | $34.58M | $152.34M | $78.09M | $34.16M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $51.36M | $55.32M | $46.44M | $53M | $48.08M | $161.66M | $85.42M | $37.06M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $64.49M | $34.15M |
| Common Stock | $54K | $51K | $49K | $48K | $48K | $9K | $9K | $9K |
| Retained Earnings | -$384.72M | -$346.3M | -$294.79M | -$239.24M | -$153M | -$90.04M | -$55.35M | -$29.48M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | -$64.49M | -$34.15M |
| Other Stockholders' Equity | $448.61M | $433.77M | $414.96M | $399.27M | $385.06M | $1.18M | $656K | $508K |
| Total Equity | $63.94M | $87.52M | $120.22M | $160.08M | $232.11M | -$88.85M | -$54.68M | -$28.96M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $115.3M | $142.84M | $166.65M | $213.07M | $280.19M | $72.81M | $30.74M | $8.09M |
| Supplementary Data | ||||||||
| Total Debt | $40.77M | $40.36M | $35.41M | $34.98M | $34.21M | $32.48M | $13.94M | $34.15M |
| Net Debt | -$51.19M | -$80M | -$102.72M | -$150.02M | -$226.48M | -$29.03M | -$7.3M | $29.91M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$38.43M | -$51.51M | -$55.55M | -$86.24M | -$62.96M | -$34.69M | -$25.87M | -$14.29M |
| Depreciation & Amortization | $487K | $712K | $614K | $710K | $632K | $554K | $295K | $63K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $7.76M | $0 | $0 | $0 |
| Stock-Based Compensation | $13.05M | $17.08M | $14.58M | $12.96M | $5.08M | $497K | $118K | $52K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $912K | $3.54M | $661K | -$6.84M | -$3.69M | -$1.48M | -$2.32M | -$1.42M |
| Inventory | -$1.44M | $1.63M | -$2.16M | -$3.25M | -$1.31M | -$1.72M | -$1.8M | -$184K |
| Accounts Payable | -$348K | $336K | -$883K | -$694K | $1.17M | $448K | $168K | $1M |
| Other Working Capital | -$5.52M | $3.49M | -$6.76M | $5.09M | -$486K | $3.53M | $3.61M | $238K |
| Total Working Capital Change | -$6.39M | $9M | -$9.13M | -$5.7M | -$4.33M | $784K | -$341K | -$358K |
| Other Non-Cash Items | $1.59M | $2.37M | $2.3M | $2.3M | $1.27M | $684K | $800K | $58K |
| Net Cash from Operating | -$29.69M | -$22.35M | -$47.18M | -$75.97M | -$52.54M | -$32.17M | -$25M | -$14.47M |
| Investing Activities | ||||||||
| Capital Expenditures | -$224K | -$385K | -$791K | -$970K | -$813K | -$953K | -$672K | -$570K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$224K | -$385K | -$791K | -$970K | -$813K | -$953K | -$672K | -$570K |
| Financing Activities | ||||||||
| Debt Repaid | - | -$4.15M | - | - | - | -$20.48M | -$14M | - |
| Common Stock Issuance | $1.85M | $1.07M | $1.33M | $1.25M | $256.68M | $0 | $0 | $12.2M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$58K | -$261K | -$224K | $0 | -$4.15M | -$154K | -$2.09M | -$23K |
| Net Cash from Financing | $1.79M | $4.96M | $1.1M | $1.25M | $252.53M | $73.4M | $42.66M | $12.2M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$28.13M | -$17.77M | -$46.87M | -$75.69M | $199.18M | $40.27M | $17M | -$2.84M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$29.69M | -$22.35M | -$47.18M | -$75.97M | -$52.54M | -$32.17M | -$25M | -$14.47M |
| Capital Expenditure | -$224K | -$385K | -$791K | -$970K | -$813K | -$953K | -$672K | -$570K |
| Free Cash Flow | -$29.92M | -$22.74M | -$47.98M | -$76.94M | -$53.35M | -$33.13M | -$25.67M | -$15.04M |
| Cash at Beginning | $120.36M | $138.13M | $185M | $260.69M | $61.51M | $21.24M | $4.24M | $7.08M |
| Cash at End | $92.23M | $120.36M | $138.13M | $185M | $260.69M | $61.51M | $21.24M | $4.24M |